These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 24108069)

  • 1. Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment.
    Steel DH; Lotery AJ
    Eye (Lond); 2013 Oct; 27 Suppl 1(Suppl 1):S1-21. PubMed ID: 24108069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic Options in Vitreomacular Traction With or Without a Macular Hole].
    Maier M; Abraham S; Frank C; Lohmann CP; Feucht N
    Klin Monbl Augenheilkd; 2016 May; 233(5):622-30. PubMed ID: 27187883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study.
    Chatziralli I; Theodossiadis G; Parikakis E; Datseris I; Theodossiadis P
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):223-33. PubMed ID: 25940555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological vitreolysis].
    Haritoglou C; Kampik A
    Ophthalmologe; 2013 Oct; 110(10):935-40. PubMed ID: 24046166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redesigning services for the management of vitreomacular traction and macular hole.
    Amoaku W; Cackett P; Tyagi A; Mahmood U; Nosek J; Mennie G; Rumney N
    Eye (Lond); 2014 Jul; 28 Suppl 1(Suppl 1):S1-10. PubMed ID: 25008433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does ocriplasmin affect the RPE-photoreceptor adhesion in macular holes?
    Hager A; Seibel I; Riechardt A; Rehak M; Joussen AM
    Br J Ophthalmol; 2015 May; 99(5):635-8. PubMed ID: 25403647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (≤400 μm) compared to tranconjunctival vitrectomy].
    Maier M; Abraham S; Frank C; Lohmann CP; Feucht N
    Ophthalmologe; 2017 Feb; 114(2):148-154. PubMed ID: 27444007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Results in Ocriplasmin Candidates With Symptomatic Vitreomacular Traction Syndrome.
    Vasquez DH; Altamirano JC; Casaus A; Del Valle RA; Gonzalez R; Gonzalez-De La Rosa A; Navarro-Partida J; Vasquez MA; Santos A
    Curr Eye Res; 2018 Feb; 43(2):208-212. PubMed ID: 29111823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography.
    Odrobina D; Michalewska Z; Michalewski J; Dzięgielewski K; Nawrocki J
    Retina; 2011 Feb; 31(2):324-31. PubMed ID: 21416651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Initial Clinical Experiences Using Ocriplasmin for the Treatment of Vitreomacular Traction with or without a Macular Hole].
    Lenk J; Matthé E; Ventzke S; Pillunat LE; Sandner D
    Klin Monbl Augenheilkd; 2018 Jan; 235(1):73-80. PubMed ID: 28282697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy and Safety Profile of Ocriplasmin in Vitreomacular Interface Disorders.
    Shaikh M; Miller JB; Papakostas TD; Husain D
    Semin Ophthalmol; 2017; 32(1):52-55. PubMed ID: 27786583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of internal limiting membrane peeling in surgery for idiopathic macular hole and the correlation between function and retinal morphology.
    Christensen UC
    Acta Ophthalmol; 2009 Dec; 87 Thesis 2():1-23. PubMed ID: 19912135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative eccentric macular holes after surgery for vitreomacular interface diseases.
    Yetkin E; Citirik M; Teke MY; Kiziltoprak H
    Int Ophthalmol; 2020 Mar; 40(3):591-596. PubMed ID: 31720973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study.
    Steel DHW; Patton N; Stappler T; Karia N; Hoerauf H; Patel N; Wachtlin J; Raber T; Kozma-Wiebe P;
    Retina; 2021 Feb; 41(2):266-276. PubMed ID: 32496343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EXPERIENCE WITH OCRIPLASMIN IN PATIENTS WITH VITREOMACULAR TRACTION SYNDROME: A RETROSPECTIVE STUDY OF 10 PATIENTS.
    Bormann C; Apitzsch BC; Habermann A; Hammer U; Hammer T
    Retin Cases Brief Rep; 2020; 14(4):377-380. PubMed ID: 29621042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Plane of Vitreoretinal Separation and Results of Vitrectomy Surgery in Patients Given Ocriplasmin for Idiopathic Macular Hole.
    Steel DH; Sandinha MT; White K
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4038-44. PubMed ID: 26098471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer retina reflectivity changes on sd-oct after intravitreal ocriplasmin for vitreomacular traction and macular hole.
    Quezada-Ruiz C; Pieramici DJ; Nasir M; Rabena M; Steinle N; Castellarin AA; Dhoot D; Couvillion S; See RF; Avery RL
    Retina; 2015 Jun; 35(6):1144-50. PubMed ID: 25961122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANATOMICAL AND FUNCTIONAL OUTCOMES OF SYMPTOMATIC IDIOPATHIC VITREOMACULAR TRACTION: A Natural History Study From the Pan American Collaborative Retina Study Group.
    Wu L; Zas M; Berrocal MH; Arevalo JF; Figueroa M; Rodriguez F; Serrano M; Graue F; Alezzandrini A; Gallego-Pinazo R; Roca JA; Iglicki M; Dalma-Weishauz J; Kozak I; Collado A; Badal J; Maia M; Salcedo-Villanueva G; Quiroz-Mercado H; Fromow-Guerra J; Lozano-Rechy D; Avila M; Chhablani J
    Retina; 2016 Oct; 36(10):1913-8. PubMed ID: 26966868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of phacoemulsification on posterior vitreous detachment formation in eyes with vitreomacular traction.
    Tieger MG; Vavvas DG
    Digit J Ophthalmol; 2023; 29(2):26-30. PubMed ID: 37727466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of ocriplasmin as a vitreolytic agent].
    Li L; Du H; Li M; Hui Y
    Zhonghua Yan Ke Za Zhi; 2015 Feb; 51(2):155-60. PubMed ID: 25908008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.